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Abstract 
Primary biliary cirrhosis (PBC) is a cholestatic liver disease of unknown cause that occurs 
most frequently in post-menopausal women.  Since the female sex hormone estrogen can be 
cholestatic, we hypothesised that PBC may be triggered in part by chronic exposure to 
xenoestrogens (which may be more active on a background of low endogenous estrogen 
levels seen in post-menopausal women).  A reporter gene construct employing a synthetic 
estrogen response element predicted to specifically interact with estrogen receptors (ER) was 
constructed. Co-transfection of this reporter into an ER null cell line with a variety of nuclear 
receptor expression constructs indicated that the reporter gene was trans-activated by ERα 
and ERβ, but not by the androgen, thyroid, progesterone, glucocorticoid or vitamin D 
receptors. Chemicals linked to PBC were then screened for xenoestrogen activity in the 
human ERα-positive MCF-7 breast cancer cell line.  Using this assay, the coal-derived food 
and cosmetic colourings - sunset yellow and tartrazine - were identified as novel human ERα 
activators, activating the human ER with an EC50% concentration of 220 and 160nM 
respectively.   
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1. Introduction 
Xenoestrogens are exogenous chemicals that are able to modulate endogenous 
estrogen activity through for example, structural similarities which result in their interactions 
with receptors or estrogen metabolising enzymes.   A common mechanism of action is for 
xenoestrogens to show an affinity for estrogen receptors (ER) and subsequently cause 
endocrine disruption through this interaction (McKenna and O’Malley, 2002).  Other 
chemicals may bind to other receptors which then interact with ERs and modulate their 
function (Huang et al., 2010). 
ERs are members of the nuclear receptor gene superfamily of transcription factors 
(Tsai and O’Malley, 1994; Hammes and Levin, 2007; see also Nuclear Receptor Signalling 
Atlas www.nursa.org/10.1621/datasets.02001).  Humans possess 2 ER genes, ERα (also 
termed ESR1 or NR3A1) and ERβ (also termed ESR2 or NR3A2).  The ERα was first 
identified and has been the most studied.  ERα is a ligand-activated nuclear receptor that 
functions through binding endogenous estrogens such as 17β-estradiol (E2) and mediating 
changes in the expression of genes regulated through ER interaction with specific genomic 
DNA sequences termed estrogen response elements (ERE) (Tsai and O’Malley, 1994; 
Hammes and Levin, 2007; see also Nuclear Receptor Signalling Atlas 
www.nursa.org/10.1621/datasets.02001).  ERs also have rapid, non-genomic effects in cells 
that modulate other signalling pathways such as kinase activities and Ca2+ mobilisation 
(Hammes and Levin, 2007).  ERα is expressed in a variety of tissues, most highly in uterine, 
ovarian, pituitary gland, vas deferens and adipose tissues (Nuclear Receptor Signalling Atlas 
www.nursa.org/10.1621/datasets.02001) and regulates the expression of greater than 2800 
genes in mammary tumour cell lines (Creighton et al., 2006).  In normal uterine cells (which 
express undetectable levels of ERβ in mouse), E2 stimulates DNA synthesis, uterine cell 
proliferation (Leroy et al., 1975; Gerchenson et al., 1984) and directly induces expression of 
c-jun, jun B and jun D (Cicatiello et al., 1992) as well as ERα (Ing and Tornesi, 1997), 
progesterone receptor (Ing and Tornesi, 1997)) and CXCL12 genes (Glace et al., 2009).  
Therefore, the primary role of ERα is the regulation of sexual reproduction, as exemplified in 
ERα knock out mice - females are infertile and males have decreased fertility (Lubahn et al., 
1993).   
ERβ is similarly transcriptionally-activated by E2 (Kuiper et al., 1998).  However, 
expression diverges from ERα, with highest levels in the ovary, lung, epididymis, prostate, 
colon and specific regions of the brain (Nuclear Receptor Signalling Atlas 
www.nursa.org/10.1621/datasets.02001).  In the normal lung (which expresses low to 
undetectable levels of ERα - Nuclear Receptor Signalling Atlas 
www.nursa.org/10.1621/datasets.02001), E2 also induces progesterone receptor expression 
(Gonzalex-Arenas et al., 2003).  However, ERβ knockout mice develop relatively normally 
and have normal fertility (Krege et al., 1998).  Ageing ERβ knockout males display signs of 
prostate and bladder hyperplasia (Krege et al., 1998).  More recently, effects on lung and 
brain development have been observed in ERβ knockout mice (Patrone et al., 2003; Wang et 
al., 2001). 
Primary biliary cirrhosis (PBC) is a cholestatic liver disease of unknown cause that 
occurs most commonly in post-menopausal women and is associated with circulating 
antibodies to mitochondrial proteins within the pyruvate dehydrogenase complex (PDC) 
(Jones, 2008).   The incidence of PBC is increased in geographical areas in close proximity to 
toxic waste sites (Ala et al., 2006).  Population-based space-time clustering suggests a 
transient environmental agent exposure is causative (McNally et al., 2009).  Since estrogens 
are cholestatic, we therefore hypothesised that xenoestrogens may have a role to play in the 
development PBC.  We have designed and validated a screening assay to identify modulators 
of human ER transcriptional activity.  A range of compounds (xenobiotic lipoic acid 
analogues, insecticides and food/cosmetic additives), exposure to which have been reported 
to be associated with an increased risk of developing PBC, have been tested for their 
estrogenic potential.  We identify, for the first time, several food and cosmetic additives as 
modulators of the human ER. 
 2. Materials and methods 
2.1. Plasmid Constructs and Materials. 
Plasmids directing the expression of a variety of human nuclear receptors – ERα, 
pCMV5-ER; the androgen receptor (AR), pCDNA3-AR-(1–918); the thyroid hormone 
receptor (TR), pVP16AD-TR; the progesterone receptor (PR), pM-PR-LBD; the 
glucocorticoid receptor (GR), pM-GR-LBD and the vitamin D receptor (VDR), pVP16AD-
VDR-LBD have been described (Brady et al., 1999; Gaughan et al., 2001). The plasmid 
directing the expression of ERβ, pCDNA3.1-nv5-ER beta was purchased from Addgene, 
Cambridge, USA).  Organophosphates (Greyhound Chemicals, Birkenhead, UK) were a gift 
from Dr Elaine Mutch (Newcastle University, UK).   All other chemicals were purchased 
from the Sigma Chemical Co. (Poole, Dorset, UK). 
 
2.2. Construction of an estrogen receptor-responsive luciferase reporter construct ((ERE)3-
pGL3).  An oligonucleotide containing three synthetic estrogen response elements was 
synthesised and hybridised with a complementary oligonucleotide (see Figure 1A) to give 
SacI and XhoI sticky ends.  Each response element consensus site was flanked with an 
identical nucleotide to its neighbour to promote sensitivity and selectivity for the estrogen 
receptor (see Supp Table 1).  The double stranded fragment was then ligated into pGL3 
promoter (Promega, Southampton, UK) and cloned in TOP10 E. coli cells (Invitrogen) using 
standard methods.  Recombinant cloned plasmids were screened by restriction digestion 
screening prior to confirming correct ligation by DNA sequencing.  
 
2.3. Cell culture.  The human breast cancer cell MCF-7 and MDA-MB321 (MDA) lines were 
originally obtained from the ATCC and Dr Elaine Mutch (Newcastle University, UK) 
respectively and were routinely cultured in low glucose Dulbecco’s-modified Eagle medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum, 80 units/ml penicillin and 80 
μg/ml streptomycin.  Cells were sub-cultured using trypsin.  The human biliary epithelial 
H69 cell line (Grubman et al., 1994) was obtained from Dr Elaine Mutch (Newcastle 
University) and routinely cultured in low glucose Dulbecco’s-modified Eagle medium 
(DMEM):Ham’s F12 medium (2:1) supplemented with 10% (v/v) fetal bovine serum, 80 
units/ml penicillin and 80 μg/ml streptomycin, 240ng/ml adenine, 27ng/ml triiodothyronine, 
10 μg/ml epinephrine, 1x insulin-transferrin-selenium solution (ITS-solution), and 1μM 
hydrocortisone. 
 
2.4. Transfection and Reporter Gene Assays.  Prior to transfection, MCF-7 and MDA cells 
lines were cultured for up to four days in culture medium supplemented with 
charcoal/dextran-stripped serum to reduce the levels of estrogen in the culture medium (May 
and Westley, 1988).  Cells in six well plates were then transfected (per well) with 1.0 µg 
(ERE)3-pGL3 and 0.5 µg of a plasmid (RL-TK) encoding the renilla luciferase protein under 
the control of a thymidine kinase promoter (Promega, Southampton, UK) to control for 
transfection efficiency with polyethylenimine (MCF-7 cells) or Effectene (MDA cells) 
transfection reagent according the manufacturer’s (Polyplus and Qiagen respectively) 
instructions.  After 24 hours, transfected cells were treated with potential ER 
agonists/antagonists from a 1000-fold molar concentrated stock in DMSO.  Control cells 
were treated with 0.1% (v/v) DMSO.  After 24 hours exposure to treatments, cells were 
harvested and luciferase and renilla activities determined using a Dual-Luc kit (Promega, 
Southampton, UK).  Luciferase activities were normalised to renilla activities and fold 
activities then compared to DMSO control treated cells as previously outlined (Haughton et 
al., 2006). 
 
2.5. RT-PCR.  Total RNA was isolated using Trizol (Invitrogen) and RT-PCR performed as 
previously described (Haughton et al., 2006) using primers given in Table 1.  SYBR green 
(Sigma, Poole, UK) was used to perform quantitative RT-PCR on an Applied Biosystems 
7500 fast real-time PCR system. 
 
2.6. Western Blotting.  Western blotting was performed as previously described (Haughton et 
al., 2006).  Rabbit polyclonal antibodies to ERα (cat # AB75635) and ERβ (cat # AB3576) 
were purchased from Abcam.  An antibody to β-actin was purchased from Chemicon (mouse 
monoclonal MAB1501).  HRP-conjugated anti-IgG antibodies were used for detection using 
the ECL reagent purchased from GE Healthcare (Amersham, UK).
 3. Results  
3.1. Validation of a screening assay for human ERα transcriptional modulators. 
A variety of sequences have been shown to mediate ER-dependent changes in gene 
transcription and a variety of “consensus” ER binding sites have been proposed.  However, 
there is no absolute consensus on the ER binding sequence and so a synthetic sequence 
(Figure 1A) based on a consensus sequence derived from a variety of natural human ER 
response elements (Supp. Table 1) was designed, with the conserved binding site sequences 
flanked with the same base present at the 5’ and 3’ end of the conserved binding site, to 
increase selectivity for the ER. 
Although a biliary epithelial cell line might be a preferred cell type to screen 
xenobiotics for both estrogenic and cholestatic activities, we failed to detect expression of ER 
genes in the human biliary cell line H-69 (Figure 1B).  The human breast cancer MCF-7 cell 
line was therefore employed.  Figure 1B and C indicate that the MCF-7 cell line used in these 
studies expressed predominantly ERα mRNA and protein after four days culture in medium 
containing “withdrawn” serum (charcoal-stripped to reduce the constitutive levels of 
estrogenic compounds present within the culture).  ERβ mRNA was detected in withdrawn 
MCF-7 cells, but not protein.  The ERα-null MDA cell line also expressed ERβ mRNA but 
not protein.  Using 17β-estradiol (E2) - the major natural estrogen in man - Figure 1D 
demonstrates that E2 induced the expression of the luciferase reporter gene in (ERE)3-pGL3 
and that the ER antagonist ICI182780 (Wakeling et al., 1991) at 10-8M inhibited both 
constitutive and E2-induced reporter gene activity in MCF-7 cells.  Other natural estrogens 
(estrone and estriol), as well as the synthetic estrogen ethinylestradiol, at 10-8M also induced 
(ERE)3-pGL3 reporter gene activity in MCF-7 cells (supplementary Figure 1).  Other steroids 
at this concentration were inhibitory (supplementary Figure 1).  In contrast, reporter gene 
expression was unaffected by E2 and ICI182780 in the ER null MDA cell line (Figure 1D).  
Co-transfecting (ERE)3-pGL3 into MDA cells with expression constructs encoding a variety 
of nuclear receptors demonstrated that only ERα and ERβ directed an induction of reporter 
gene activity in response to E2 (Figure 1E).   
The TTF1 gene has been shown to be an ERα-inducible gene in MCF-7 cells (May 
and Westley, 1988).  Primers to a region of this transcript were designed and RT-PCR 
amplified a single amplicon of the predicted size (Figure 2A).  Figure 2B shows that TTF1 
mRNA was induced by E2 and that this induction was antagonised by ICI182780 in MCF-7 
cells.  No induction occurred in MDA cells (Figure 2B).    
  
3.2. Screening a variety of xenobiotics for their ability to modulate human ERα 
transcriptional function. 
 
Xenobiotic lipoic acid analogues are primarily ERα antagonists.  PBC is associated with 
the presence of anti-mitochondrial antibodies which most commonly immunoreact with the 
lipoylated E2 component of the pyruvate dehydrogenase complex (PDC-E2) (Jones, 2008).   
It has been proposed that the mechanism for the initiation of tolerance breakdown in PBC is 
immune recognition of neo-antigens formed by xenobiotic substitution of lipoic acid in 
proteins (Leung et al., 2003).   Thus, sensitization with proteins substituted with the lipoic 
acid analogue 6-bromohexanoic acid (6BH) can induce an immune response that cross-reacts 
with PDC-E2 (Walden et al., 2008). 
Figure 3 demonstrates that a number of xenobiotics with the potential to substitute 
lipoic acid in PDC-E2 modulate ERα transcriptional activity.  However, none of these 
compounds acted as an ERα agonist and many inhibited constitutive reporter gene expression 
(without causing any overt toxicity, and therefore are unlikely to promote cholestasis via an 
ER-dependent mechanism).  
 Insecticides / organophosphates.  Pesticides may give rise an autoimmune response although 
their effects remain poorly defined and little investigated (Holsapple, 2002).  However, since 
some pesticides have been reported to be xenoestrogens (Laws et al., 2000), a range of 
chlorinated pesticides and organophosphates were examined for their ability to activate the 
human ERα.  Figure 4 demonstrates that only methoxychlor activated the human ERα 
whereas most compounds had either no effect or inhibited constitutive reporter gene 
expression (and therefore are unlikely to promote cholestasis via an ER-dependent 
mechanism). 
 
Food and cosmetic additives.  Epidemiological studies have made an association between 
PBC incidence and cosmetic use (e.g. frequent nail polish use (Gershwin et al., 2005), hair 
dye use (Prince et al., 2010)).  Figure 5 demonstrates that some constituents of cosmetics 
such as paraben esters, are human ERα agonists (as previously reported (Routledge et al., 
1998)), in our assay.  In addition the cosmetic and food additives sunset yellow and tartrazine 
were also shown to be ERα agonists (Figure 5).  As previously reported (Kuiper et al., 1998), 
the phytoestrogen genistein was also shown to be an ERα agonist (Figure 5). 
Selected xenoestrogens identified in these studies were then tested for their ability to 
transcriptionally activate the human ERα. Inhibition of their induction of (ERE)3-pGL3 
reporter by the ER antagonist ICI182780 was also determined, to confirm that the compounds 
interact with the ERα (and not another trans-activating receptor) in MCF-7 cells.  Figure 6A 
demonstrates that (ERE)3-pGL3 reporter gene activity induced by E2 as well as by sunset 
yellow, tartrazine, butylparaben and propylparaben were inhibited by ICI182780.  These data 
were also confirmed at the level of TTF1 mRNA induction (Figure 6B). 
 
Food and cosmetics are potent human ERα modulators of transcriptional function. 
To our knowledge, food / cosmetic additives such as sunset yellow and tartrazine have not 
been examined and/or reported to be estrogenic chemicals.  Accordingly, we investigated 
their potency of action in the MCF-7 / (ERE)3-pGL3 reporter gene assay.  Figure 7A  
illustrates a typical dose – response for E2 and sunset yellow on relative reporter gene 
expression in MCF-7 cells transfected with (ERE)3-pGL3.  Figure 7B shows the dose-
response effect of ICI182780 on E2-induced reporter gene activity.  These data were used to 
calculate EC50% and IC50% values for a range of compounds and Table 2 demonstrates that the 
food colourings tartrazine and sunset yellow - the most potent xenoestrogens examined in this 
study -  were approximately 50 times less effective that E2 at activating the human ERα in 
the MCF-7 / (ERE)3-pGL3 reporter gene assay.  Table 2 also demonstrates that the food 
colourings are more potent activators of the human ERα than the parabens compounds. 
 
4. Discussion 
This paper describes the use of a reporter gene system in MCF-7 cells to screen for 
compounds which have the potential to modulate human ER transcriptional activity.  
Although, in the context of PBC, it may be preferable to use a biliary epithelial cell line for 
these studies, the only available human cell line – H-69 – did not express ER (in contrast to 
biliary epithelial cells in vivo (Alvaro et al., 2000; Alvaro et al., 2004). However, the widely 
employed MCF-7 cell line remains an excellent model system in which to screen for potential 
estrogenicity in man (Gutendorf and Westendorf, 2001).  It is likely that reporter gene 
expression in the MCF-7 cells employed was predominantly associated with ERα activity 
since we could not detect ERβ protein in these cells (although its mRNA was detectable).  
The assay system is likely to be relatively specific to ERs since over-expression of a variety 
of nuclear receptors – in contrast to ERα and ERβ – failed to trans-activate the reporter gene 
construct in an ER null cell line.  However, there are 48 nuclear receptor genes in man 
(Zhang et al., 2004) and it cannot be excluded that another nuclear receptor expressed in 
MCF-7 cells might trans-active the reporter gene. 
Interestingly, despite MCF-7 cultures undergoing a four day withdrawal process 
whereupon the cells are cultured in serum exposed to charcoal (which adsorbs many low 
molecular weight chemicals such as steroids), reporter gene activity remained further 
inhibited by the ER antagonist ICI182780 by up to 90%.  This suggests that either estrogens 
remain in the culture despite the withdrawal process or that un-liganded ER remains able to 
trans-activate the reporter gene construct.  If the former is the case, then this assay system has 
the capacity to respond to lower concentrations of estrogen.   
Although the MCF-7 cell provides an assay system for identifying predominantly 
ERα regulators, the reporter gene construct was also trans-activated by ERβ.  A cell line 
expressing ERβ – but not ERα - was not identified and so screening for ERβ-specific 
regulators could not be undertaken.  Screening a range of compounds identified two food and 
cosmetic colouring agents – tartrazine and sunset yellow (for structures see supplementary 
Figure 2) – as human ER activators.  To our knowledge, these compounds have not been 
shown to be xenoestrogen 
There are two competing mechanisms proposed for inducing cholestasis in pregnancy 
or through clinical use of estrogen therapies.  The mechanism proposed by Negishi and co-
workers is that the expression of many bile acid and drug transporters are transcriptionally 
repressed by ERα activation (Yamamoto et al., 2006).  In contrast, Steiger and co-workers 
propose that estrogen and/or its hepatic metabolites inhibit the activity of bile acid and drug 
transporters (Steiger et al., 2000).   In either case, xenoestrogens have the capacity to cause 
cholestasis through the same mechanisms since they are reliant on molecular mimicry of 
estrogens.  A question remains as to the likelihood that tartrazine or sunset yellow could 
cause an estrogenic effect and cholestatic effect in the liver.  Both compounds are water 
soluble and are not likely to be appreciably absorbed via the gut or skin (in the case of 
cosmetic use).  However, gut and skin permeability can be affected by other agents (e.g. 
alcohol and other agents which are added to cosmetics respectively).  There is a wealth of 
evidence that gut permeability and its consequent effect on inflammation in the liver is a 
major determinant on the development of alcoholic liver disease (Rao, 2009; Szabo et al., 
2010).  Given the EC50% values for sunset yellow and tartrazine determined in these studies 
(220 and 160nM respectively), the question arises as to whether exposure to these dyes could 
result in a estrogenic effect in man.  Taking dietary intake alone (which is not the only source 
of exposure), teir 3 refined exposure analysis indicates that 95th or 97.5th percentile exposure 
levels are calculated to be potentially upto 7.3 and 5.8 mg/kg body weight/day for tartrazine 
and sunset yellow respectively (EFSA Panel on Food Additives and Nutrient Sources added 
to Food (ANS), 2009;  European Food Safety Authority, 2011).  Assuming this maximum 
dose is taken as a bolus; that only 10% is absorbed and systemically available; that the 
compounds are completely distributed around the body and that absorbtion, metabolism and 
elimination effectively reduce the maximum concentration of the compounds by 50%, serum 
concentrations of 685nM and 640nm for tartrazine and sunset yellow respectively are 
calculated.  These values are in excess of their EC50% values for the ERα determined in these 
studies and therefore suggest that in high exposed individuals, intake may be sufficient for 
these chemicals to have an estrogenic effect.    It should also be noted that estrogens have 
been shown to cause genomic instability – at least in cancer cell lines – via an ER-
independent mechanism (Yared et al., 2002; Kabil et al., 2008).  Xenoestrogens may also act 
similarly and this effect may further contribute to cholestatic injury.  Since the mechanism 
appears to be mediated via Src/Raf/Erk signalling mechanism independent of the ER (Kabil 
et al., 2008), the ER reporter system employed in these experiments would not identify 
chemicals that might also act via this pathway. 
Our data suggest that compounds like tartrazine and sunset yellow – whilst not the 
cause - may be a component contributor to the development of cholestasis and which in 
combination with other factors, could pre-dispose to the development of PBC. 
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 Fig. 1.  The (ERE)3-pGL3 reporter gene is transcriptionally regulated by human ERα 
and ERβ.   A, concatamer of 3 synthetic ERE response elements (shaded) inserted upstream 
of the minimal promoter sequence in pGL3-promoter luciferase reporter gene construct.  B, 
RT-PCR for the expression of the indicated human transcript in a variety of human cell lines 
transfected with the ERE3-pGL3 construct.  C, Western blot for the expression of ER proteins 
in cell lines (30 µg cell protein/lane).  D, (ERE)3-pGL3 reporter gene expression after 
transfection in the indicated cell line - mean and standard deviation normalized ERE3-pGL3 
reporter gene expression from 3 separate transfections in the same experiment, typical of at 
least 3 separate experiments.  *Significantly different (P > 95%) versus the DMSO vehicle 
treated cells using the Student’s T test (two tailed).  E, (ERE)3-pGL3 reporter gene 
expression after transfection of MDA cells with either GFP (as control) or an expression 
vector encoding the indicated nuclear receptor - mean and standard deviation normalized 
ERE3-pGL3 gene expression relative to GFP transfected/DMSO treated cells from 3 separate 
transfections in the same experiment, typical of at least 2 separate experiments.  
*Significantly different (P > 95%) versus the GFP-transfected/DMSO vehicle-treated cells 
using the Student’s T test (two tailed). 
 
 Fig 2.  TTF1 mRNA is induced by the ER in MCF-7 cells.  A, agarose gel electrophoresis 
of PCR products after quantitative RT-PCR amplification from either DMSO vehicle or E2-
treated MCF-7 cells.  Each lane represents a PCR product from a separate well of cells from 
the same experiment, typical of 7 separate experiments.  B, TFF1 mRNA expression in the 
indicated cell line after treatment as indicated for 24 hours - mean and standard deviation 
levels (normalized to 18S rRNA) and expressed as fold the levels in DMSO control-treated 
cells for each cell line.  Results are from 3 separate determinations from the same experiment, 
typical of at least 3 separate experiments.  *Significantly different (P > 95%) versus the 
DMSO vehicle treated cells using the Student’s T test (two tailed). 
 Fig. 3.  Screening lipoic acid analogues for their ability to modulate human ER 
transcriptional activity.  (ERE)3-pGL3 reporter gene expression after transfection in MCF-7 
cells and treatment as indicated - mean and standard deviation normalized (ERE)3-pGL3 
reporter gene expression from 3 separate transfections in the same experiment, typical of at 
least 3 separate experiments.  *Significantly different (P > 95%) versus the DMSO vehicle 
treated cells using one way ANOVA (two tailed).   
 Fig. 4.  Screening insecticides and organophosphates for their ability to modulate 
human ER transcriptional activity.  (ERE)3-pGL3 reporter gene expression after 
transfection in MCF-7 cells and treatment as indicated - mean and standard deviation 
normalized (ERE)3-pGL3 reporter gene expression from 3 separate transfections in the same 
experiment, typical of at least 3 separate experiments.  *Significantly different (P > 95%) 
versus the DMSO vehicle treated cells using one way ANOVA (two tailed).   
 
 Fig. 5.  Screening food and cosmetic additives for their ability to modulate human ER 
transcriptional activity.  (ERE)3-pGL3 reporter gene expression after transfection in MCF-7 
cells and treatment as indicated - mean and standard deviation normalized (ERE)3-pGL3 
reporter gene expression from 3 separate transfections in the same experiment, typical of at 
least 3 separate experiments.  *Significantly different (P > 95%) versus the DMSO vehicle 
treated cells using one way ANOVA (two tailed).   
 
Fig. 6.  Confirmation of human ER activation by xenobiotics.  A, (ERE)3-pGL3 reporter 
gene expression after transfection in MCF-7 cells and treatment as indicated - mean and 
standard deviation normalized (ERE)3-pGL3 reporter gene expression from 3 separate 
transfections in the same experiment, typical of at least 3 separate experiments.    ICI182780 
or its vehicle control solvent were added to cells 24 hours prior to addition of potential ER 
activator and re-treated at the time of addition of potential ER activator.  Significantly 
different (P > 95%) versus the *DMSO vehicle treated cells or # potential ER activator only-
treated cells using one way ANOVA (two tailed).  B, TFF1 mRNA expression in the 
indicated cell line after treatment as indicated for 24 hours -  ICI182780 or its vehicle control 
solvent were added to cells 24 hours prior to addition of potential ER activator and re-treated 
at the time of addition of potential ER activator.  Data are the mean and standard deviation 
levels (normalized to 18S rRNA) and expressed as fold the levels in DMSO control-treated 
cells for each cell line.  Results are from 3 separate determinations from the same experiment, 
typical of at least 3 separate experiments.  *Significantly different (P > 95%) versus the 
DMSO vehicle treated or # potential ER activator only-treated cells using one way ANOVA 
(two tailed). 
 
 Fig 7.  Dose-response regulation of (ERE)3-pGL3 reporter gene expression.  A – B, 
(ERE)3-pGL3 reporter gene expression after transfection in MCF-7 cells and treatment with 
the indicated activator or antagonist  - mean and standard deviation normalized (ERE)3-pGL3 
reporter gene expression from 3 separate transfections in the same experiment, typical of at 
least 3 separate experiments. 
 
 Supplementary FIG. 1.  Estrogens transactivate the (ERE)3-pGL3 construct in MCF-7 
cells.  (ERE)3-pGL3 reporter gene expression after transfection in MCF-7 cells and treatment 
as indicated - ICI182780 or its vehicle control solvent were added to cells 24 hours prior to 
addition of potential ER activator and re-treated at the time of addition of potential ER 
activator.  Data are the mean and standard deviation normalized (ERE)3-pGL3 reporter gene 
expression from 3 separate transfections in the same experiment, typical of at least 3 separate 
experiments.  *Significantly different (P > 95%) versus the DMSO vehicle treated cells using 
the Student’s T test (two tailed).  $Significantly different (P > 95%) versus ICI182780 only 
treated cells using one way ANOVA (two tailed). 
 Supplementary FIG. 2.  Structures of E2, tartrazine and sunset yellow. 
